SCHEMBL24066489

SCHEMBL24066489

c1ccc(N(c2ccc3oc4ccccc4c3c2)c2cc(N(c3ccccc3)c3ccc4oc5ccccc5c4c3)c3ccc4ccccc4c3c2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 8/20 0.41
▸ HPGD P15428 5/20 0.41
▸ MAPT P10636 5/20 0.41
▸ GLA P06280 3/20 0.41
▸ TSHR P16473 2/20 0.41
▸ HSD17B10 Q99714 2/20 0.41
▸ TDP1 Q9NUW8 2/20 0.41
▸ L3MBTL1 Q9Y468 2/20 0.41
▸ HTT P42858 1/20 0.41
▸ ALDH1A1 P00352 9/20 0.39
▸ GAA P10253 3/20 0.39
▸ NPC1 O15118 2/20 0.38
▸ RAB9A P51151 2/20 0.38
▸ GPR55 Q9Y2T6 1/20 0.38
▸ HNF4A P41235 1/20 0.37
▸ MEN1 O00255 2/20 0.37
▸ KMT2A Q03164 2/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ NISCH Q9Y2I1 1/20 0.36
▸ SIRT2 Q8IXJ6 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24066582 1.00 KDM4E (0.41) KDM4EHPGDMAPTGLATSHR
SCHEMBL26851733 0.99 KDM4E (0.40) KDM4EHPGDMAPTGLATSHR
SCHEMBL24066684 0.95 AHR (0.37) KDM4EHPGDMAPTGLATSHR
SCHEMBL26851764 0.94 AHR (0.36) KDM4EHPGDMAPTGLATSHR
SCHEMBL12206616 0.94 KDM4E (0.42) KDM4EHPGDMAPTGLATSHR
SCHEMBL26851419 0.91 KDM4E (0.38) KDM4EHPGDMAPTGLATSHR
SCHEMBL24066572 0.90 KDM4E (0.34) KDM4EHPGDMAPTGLATSHR
SCHEMBL26530647 0.90 MAPT (0.39) KDM4EHPGDMAPTGLATSHR
SCHEMBL26055842 0.90 KDM4E (0.41) KDM4EHPGDMAPTGLATSHR
SCHEMBL26851790 0.89 KDM4E (0.36) KDM4EHPGDMAPTGLATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230225197-A1 ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME DUPONT SPECIALTY MATERIALS KOREA LTD. (KR) 2023-07-13 — — US disclosed
US-20230225197-A1 ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME DUPONT SPECIALTY MATERIALS KOREA LTD. (KR) 2023-07-13 — — US disclosed
US-20210376240-A1 ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME ROHM AND HAAS ELECTRONIC MATERIALS KOREA LTD. (KR) 2021-12-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210376240-A1 ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME OR10J3, VDAC2, L1CAM KDM4E 1028/4885HPGD 4129/4885MAPT 1398/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback